RANK expression as a prognostic and predictive marker in breast cancer.
about
RANK-RANKL signalling in cancerBone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myelomaRANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.Progestogens and risk of breast cancer: a link between bone and breast?Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort.RANK as a therapeutic target in cancer.Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657).Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy.RANKL inhibitors for osteosarcoma treatment: hope and caution.MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonistsProspects of adjuvant RANKL inhibition in breast cancer?Immunohistochemical and quantitative RT-PCR methods to assess RANK expression in normal and neoplastic canine mammary gland.Bone-Targeted Therapies in Cancer-Induced Bone Disease.Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy.Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer.
P2860
Q26747442-8A4829C5-B200-4CF8-BA89-0BC24AA204DEQ28081996-56DF0B13-9BDB-4CC0-83C8-E794599C3B4AQ35218182-D557700A-1788-4CC5-913C-8B7E6CF1D40BQ36356112-12336A49-56DA-4EE7-917B-7C73F55807DAQ38572022-C6AE1E57-6A62-4A2E-9A6A-B3285F56FF93Q38682103-C09A1ABB-21FC-4B7E-B139-86D191EE7DF5Q38691526-EDE72AE5-E6D7-4CD5-867C-5D8F0BFBBE78Q38747404-2A5192AF-2331-45F3-895D-876F8E422AC8Q38833288-172C4F87-5C0F-492E-96B3-7F0E6DAA1A33Q41200607-29791340-D1B7-450A-80A6-F0688B826406Q42330824-007701AB-0AC8-482D-843A-DD03CE473D97Q42380563-AB710038-4F87-4542-B4FF-07C8EFA5AB8FQ43142242-7BF16539-E47E-4DDD-9A20-C7FC878B787FQ47666371-DADCCC5D-E93B-40AA-A9E7-A6FD6A27F717Q48110513-AF28A15E-9B6B-446F-A1C5-51ED602BFA64Q50071959-51D034CD-24E0-4BD4-9744-91A8AE04E146Q54186456-2AE733DF-FD64-47EA-9916-AE024A193FAF
P2860
RANK expression as a prognostic and predictive marker in breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
RANK expression as a prognostic and predictive marker in breast cancer.
@en
RANK expression as a prognostic and predictive marker in breast cancer.
@nl
type
label
RANK expression as a prognostic and predictive marker in breast cancer.
@en
RANK expression as a prognostic and predictive marker in breast cancer.
@nl
prefLabel
RANK expression as a prognostic and predictive marker in breast cancer.
@en
RANK expression as a prognostic and predictive marker in breast cancer.
@nl
P2093
P2860
P50
P1476
RANK expression as a prognostic and predictive marker in breast cancer
@en
P2093
Berit Maria Pfitzner
Daniel Branstetter
Frank Dombrowski
Martin Werner
Sibylle Loibl
Thomas Rüdiger
William C Dougall
P2860
P2888
P304
P356
10.1007/S10549-014-2955-1
P407
P577
2014-04-16T00:00:00Z